{
    "organizations": [],
    "uuid": "171f57eff9c68c64288ea9bb42f61c624ec71605",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-alnylam-reports-new-clinical-resul/brief-alnylam-reports-new-clinical-results-from-the-apollo-phase-3-study-of-patisiran-idUSFWN1S10LG",
    "ord_in_thread": 0,
    "title": "BRIEF-Alnylam Reports New Clinical Results From The Apollo Phase 3 Study Of Patisiran",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Alnylam Pharmaceuticals Inc:\n* ALNYLAM REPORTS NEW CLINICAL RESULTS FROM THE APOLLO PHASE 3 STUDY OF PATISIRAN AT THE AMERICAN ACADEMY OF NEUROLOGY 2018 ANNUAL MEETING\n* ALNYLAM PHARMA - IN NEW POST-HOC ANALYSIS, PATISIRAN REDUCED COMPOSITE RATE OF ALL-CAUSE HOSPITALIZATION, MORTALITY BY ABOUT 50%, RELATIVE TO PLACEBO\n* ALNYLAM PHARMACEUTICALS INC - PATISIRAN DEMONSTRATED IMPROVEMENT IN MULTIPLE QUALITY OF LIFE MEASURES, COMPARED TO PLACEBO Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-04-24T19:07:00.000+03:00",
    "crawled": "2018-04-25T14:23:15.020+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "alnylam",
        "pharmaceutical",
        "inc",
        "alnylam",
        "report",
        "new",
        "clinical",
        "result",
        "apollo",
        "phase",
        "study",
        "patisiran",
        "american",
        "academy",
        "neurology",
        "annual",
        "meeting",
        "alnylam",
        "pharma",
        "new",
        "analysis",
        "patisiran",
        "reduced",
        "composite",
        "rate",
        "hospitalization",
        "mortality",
        "relative",
        "placebo",
        "alnylam",
        "pharmaceutical",
        "inc",
        "patisiran",
        "demonstrated",
        "improvement",
        "multiple",
        "quality",
        "life",
        "measure",
        "compared",
        "placebo",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}